Behçet's disease: Comparing 3 decades of treatment response at the National Eye Institute

Canadian Journal of Ophthalmology

Volumn 43, Issue 4, 2008, Pages 468-472

  Kump, Leila I ^a   Moeller, Kristy L ^a   Reed, George F ^a   Kurup, Shree K ^a   Nussenblatt, Robert B ^a   Levy Clarke, Grace A ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Autoimmune diesease; Beh et's disease; Ocular inflammation; Uveitis

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACLIZUMAB; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID;

ADOLESCENT; ADULT; ARTICLE; BEHCET DISEASE; CHILD; CLINICAL PROTOCOL; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MONOTHERAPY; SCORING SYSTEM; STATISTICAL ANALYSIS; UVEITIS; VISUAL ACUITY;

EID: 49949088549     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I08-080     Document Type: Article

References (22)

1. Zouboulis CC, Keitel W. A historical review of early descriptions of Adamantiades-Behçet's disease. J Invest Dermatol 2002; 119:201-5.
2. Adamantiades B. Sur un cas d'iritis á hypopion récidivant. Ann Ocul (Paris) 1931;168:271-8.
3. Behçet H. Über rezidivierende, aphthöse, durch ein Virus verursachte Geschwüre im Mund, am Auge und an den Genitalien. Dermatol Wochenschr 1937;105:1152-7.
4. Mochizuki M, Akduman L, Nussenblatt RB. Behçet's disease. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St. Louis, Mo.: Mosby; 1996:663-75.
5. Nussenblatt RB, Whitcup SM. Behçet's disease. In: Nussenblatt RB, Whitcup SM, eds. Uveitis: Fundamentals and Clinical Practice. St. Louis, Mo.: Mosby; 2004:350-71.
6. International Study Group for Behçet's Disease. Evaluation of diagnostic ("classification") criteria in Behçet's disease: toward internationally agreed criteria. Lancet 1990; 335:1078-80.
7. Mamo FG. The rate of visual loss in Behçet's disease. Arch Ophthalmol 1970;84:451-2.
8. Mishima S, Masuda K, Izawa Y, Namba K. The eighth Frederick H. Verhoeff Lecture. Presented by Saiichi Mishima, MD. Behçet's disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 1979; 77:225-79.
9. Benezra D, Cohen E. Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol 1986;70:589-92.
10. Tugal-Tutkun I, Sumru O, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 2004;138:373-80.
11. Ando K, Fujino Y, Hijikata K, Izawa Y, Masuda K. Epidemiologic features and visual prognosis of Behçet's disease. Jpn J Ophthalmol 1999;43:312-7.
12. Sukegawa S, Ujihara H, Miyanaga Y. Long term visual outcome in patients with Behçet's disease. Implication of immunosuppressants and cataract. Jpn J Clin Ophthalmol 1997;51:1157-60.
13. Sakamoto M, Akazawa K, Nishioka Y, Sanui H, Inomata H, Nose Y. Prognostic factors of vision in patients with Behçet's disease. Ophthalmology 1995;102:317-21.
14. Yoshida A, Kawashima H, Motoyama Y, et al. Comparison of patients with Behçet's disease in the 1980s and 1990s. Ophthalmolagy 2004;111:810-5.
15. Demiroglu H, Barista I, Dundar S. Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey. Ophthalmology 1997;104:701-5.
16. Atmaca LS. Fundus changes associated with Behcet's disease. Graefes Arch Clin Exp Ophthalmol 1989;227:340-4.
17. Ozdal PC, Ortac S, Taskintuna I, Firat E. Posterior segment involvement in ocular Behçet's disease. Eur J Ophthalmol 2002; 12:424-31.
18. Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behçet's syndrome: a 2 decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003;82:60-76.
19. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease. Int J Dermatol 2003;42:346-51.
20. Barra C, Belfort R, Abreu MT, Kim K, Martins MC, Petrilli AM. Behçet's disease in Brazil: a review of 49 cases with emphasis on ophthalmic manifestations. Jpn J Ophthalmol 1991;35: 339-46.
21. Ambresin A, Tao Tran V, Spertini F, Herbort CP. Behçet's disease in western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm 2002;10:53-63.
22. Colvard DM, Robertson DM, O'Duffy JD. The ocular manifestations of Behçet's disease. Arch Ophthalmol 1977;95: 1813-7.